{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:25:17Z","timestamp":1792686317359,"version":"4.5.0"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bladder cancer (BCa) is one of the most common malignancies worldwide, and its prognostication and treatment remains challenging. The fast growth of various cancer cells requires reprogramming of its energy metabolism using aerobic glycolysis as a major energy source. However, the prognostic and therapeutic value of glycolysis-related genes in BCa remains to be determined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The fused merge dateset from TCGA, GSE13507 and GSE31684 were used for the analysis of glycolysis-related genes expression or subtyping; and corresponding clinical data of these BCa patients were also collected. In the merge cohort, we constructed a 18 multigene signature using the least absolute shrinkage and selection operator (LASSO) Cox regression model. The four external cohorts (i.e., IMvigor210, GSE32894, GSE48276 and GSE48075) of BCa patients were used to validate the accuracy. We evaluated immune infiltration using seven published algorithms: CIBERSORT, QUANTISEQ, XCELL, TIMER, CIBERSORT-ABS, EPIC, and MCPCOUNTER. Subsequently, in order to analyze the correlation between risk groups(scores) and overall survival, recognised immunoregolatory cells or common chemotherapeutic agents, clinicopathological data and immune checkpoint-related genes of BCa patients, Wilcox rank test, chi-square test, cox regression and spearman's correlation were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Conspicuously, we could see that CD8+ T, cancer associated fibroblast, macrophage M2, NK, endothelial cells and so on were significantly dysregulated between the two risk groups. In addition, compared with the low-risk group, high-risk group predicted poor prognosis and relatively weak sensitivity of chemotherapy. Additionally, we also found that the expression level of partial genes in the model was significantly correlated with objective responses to anti-PD-1 or anti-PD-L1 treatment in the IMvigor210, GSE111636, GSE176307,  GSE78220 or GSE67501 cohort; and its expression level was also varied in different objective response cases receiving tislelizumab combined with low-dose nab-paclitaxel therapy based on our mRNA sequencing (TRUCE-01). According to \u201cGSEA\u201d algorithm of R package \u201cclusterProfiler\u201d, the most significantly enriched HALLMARK, KEGG pathway and GO term was separately the \u2018Epithelial Mesenchymal Transition\u2019, \u2018Ecm Receptor Interaction\u2019 and \u2018MF_Extracellular_matrix_structural_constitunet\u2019 in the high- vs. low-risk group. Subsequently, we verified the protein and mRNA expression of interested model-related genes from the Human Protein Atlas (HPA) and 10 paired BCa tissues collected by us. Furthermore,\n                      <jats:italic>in vitro<\/jats:italic>\n                      functional experiments demonstrated that FASN was a functional oncogene in BCa cells through promoting cell proliferation, migration, and invasion abilities.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In summary, the glycolysis-associated gene signature established by us exhibited a high predictive performance for the prognosis, immunotherapeutic responsiveness, and chemotherapeutic sensitivity of BCa. And, The model also might function as a chemotherapy and immune checkpoint inhibitor (ICI) treatment guidance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2024.1430583","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T01:16:10Z","timestamp":1736471770000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Development and validation of a glycolysis-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer"],"prefix":"10.3389","volume":"15","author":[{"given":"Chong","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqian","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoliang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrc3817","article-title":"Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity","volume":"15","author":"Knowles","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The warburg effect: how does it benefit cancer cells","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2018.03.001","article-title":"How the Warburg effect supports aggressiveness and drug resistance of cancer cells","volume":"38","author":"Icard","year":"2018","journal-title":"Drug Resist Update"},{"key":"B6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ctrv.2016.03.005","article-title":"Metabolic phenotype of bladder cancer","volume":"45","author":"Massari","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1016\/j.cmet.2021.11.011","article-title":"NEAT1 is essential for metabolic changes that promote breast cancer growth and metastasis","volume":"33","author":"Park","year":"2021","journal-title":"Cell Metab"},{"key":"B8","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ccell.2018.01.010","article-title":"Transcriptional regulation of the warburg effect in cancer by SIX1","volume":"33","author":"Li","year":"2018","journal-title":"Cancer Cell"},{"key":"B9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s13046-022-02531-x","article-title":"Aerobic glycolysis enhances HBx-initiated hepatocellular carcinogenesis via NF-\u03baBp65\/HK2 signalling","volume":"41","author":"Chen","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322780","article-title":"F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer","volume":"70","author":"Hong","year":"2021","journal-title":"Gut"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202702","article-title":"Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells","volume":"191","author":"Husain","year":"2013","journal-title":"J Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nov125","article-title":"Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions","volume":"18","author":"Agnihotri","year":"2016","journal-title":"Neuro Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2015.111","article-title":"Targeting glycogen metabolism in bladder cancer","volume":"12","author":"Ritterson Lew","year":"2015","journal-title":"Nat Rev Urol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0758","article-title":"The tumor immune microenvironment drives a prognostic relevance that correlates with bladder cancer subtypes","volume":"7","author":"Pfannstiel","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.77","article-title":"Tumour acidosis: from the passenger to the driver's seat","volume":"17","author":"Corbet","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0203-7","article-title":"Navigating metabolic pathways to enhance antitumour immunity and immunotherapy","volume":"16","author":"Li","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2017.04.002","article-title":"Linking tumor glycolysis and immune evasion in cancer: Emerging concepts and therapeutic opportunities","volume":"1868","author":"Ganapathy-Kanniappan","year":"2017","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"BSR20203982","DOI":"10.1042\/BSR20203982","article-title":"Correlations between glycolysis with clinical traits and immune function in bladder urothelial carcinoma","volume":"41","author":"Che","year":"2021","journal-title":"Biosci Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.03.068","article-title":"Increased glycolysis correlates with elevated immune activity in tumor immune microenvironment","volume":"42","author":"Jiang","year":"2019","journal-title":"EBioMedicine"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.60","article-title":"Targeting cellular metabolism to improve cancer therapeutics","volume":"4","author":"Zhao","year":"2013","journal-title":"Cell Death Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.6189","article-title":"Glycometabolic adaptation mediates the insensitivity of drug-resistant K562\/ADM leukaemia cells to adriamycin via the AKT-mTOR\/c-Myc signalling pathway","volume":"15","author":"Zhang","year":"2017","journal-title":"Mol Med Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2024.04.020","article-title":"Phase 2 study of preoperative tislelizumab in combination with low-dose nab-paclitaxel in patients with muscle-invasive bladder cancer","author":"Wu","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14681","article-title":"Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinoma","volume":"112","author":"Ye","year":"2021","journal-title":"Cancer Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.14134","article-title":"Genetic and immune characteristics of multiple primary lung cancers and lung metastases","volume":"12","author":"Yang","year":"2021","journal-title":"Thorac Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.4RI0818-311R","article-title":"Monocyte heterogeneity and functions in cancer","volume":"106","author":"Olingy","year":"2019","journal-title":"J Leukoc Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nri2742","article-title":"T(H)17 cells in tumour immunity and immunotherapy","volume":"10","author":"Zou","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4330","DOI":"10.3390\/ijms20184330","article-title":"Systematic identification of characteristic genes of ovarian clear cell carcinoma compared with high-grade serous carcinoma based on RNA-sequencing","volume":"20","author":"Nagasawa","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"20584","DOI":"10.1038\/s41598-021-00043-w","article-title":"Effects and prognostic values of miR-30c-5p target genes in gastric cancer via a comprehensive analysis using bioinformatics","volume":"11","author":"Hu","year":"2021","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-2099","article-title":"Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer","volume":"69","author":"Xu","year":"2009","journal-title":"Cancer Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.98","article-title":"Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer","volume":"35","author":"Englund","year":"2016","journal-title":"Oncogene"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-018-2626-4","article-title":"Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway","volume":"144","author":"Liu","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.21176","article-title":"Cartilage oligomeric matrix protein promotes prostate cancer progression by enhancing invasion and disrupting intracellular calcium homeostasis","volume":"8","author":"Englund","year":"2017","journal-title":"Oncotarget"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-007-0199-5","article-title":"The SPINK gene family and celiac disease susceptibility","volume":"59","author":"Wapenaar","year":"2007","journal-title":"Immunogenetics"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.6679","article-title":"Association and diagnostic value of serum SPINK4 in colorectal cancer","volume":"7","author":"Xie","year":"2019","journal-title":"PeerJ"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1103048","article-title":"HLA-DQA2 and HLA-DQB2 genes are specifically expressed in human Langerhans cells and encode a new HLA class II molecule","volume":"188","author":"Lenormand","year":"2012","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2006.08.002","article-title":"Expression and cellular localisation of chloride intracellular channel 3 in human placenta and fetal membranes","volume":"28","author":"Money","year":"2007","journal-title":"Placenta"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.8348","article-title":"Prognostic value of CLIC3 mRNA overexpression in bladder cancer","volume":"8","author":"Chen","year":"2020","journal-title":"PeerJ"},{"key":"B39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/onc.2016.172","article-title":"Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response","volume":"36","author":"Nickerson","year":"2017","journal-title":"Oncogene"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1995.75.4.835","article-title":"Role of microtubule-associated proteins in the control of microtubule assembly","volume":"75","author":"Maccioni","year":"1995","journal-title":"Physiol Rev"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200110134","article-title":"MAP2 is required for dendrite elongation, PKA anchoring in dendrites, and proper PKA signal transduction","volume":"158","author":"Harada","year":"2002","journal-title":"J Cell Biol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2009.01020.x","article-title":"Increased expression of MAP2 inhibits melanoma cell proliferation, invasion and tumor growth in vitro and in vivo","volume":"19","author":"Song","year":"2010","journal-title":"Exp Dermatol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002490","article-title":"Genome-wide association study identifies novel loci associated with circulating phospho- and sphingolipid concentrations","volume":"8","author":"Demirkan","year":"2012","journal-title":"PloS Genet"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1577126","article-title":"CYTL1 inhibits tumor metastasis with decreasing STAT3 phosphorylation","volume":"8","author":"Wang","year":"2019","journal-title":"Oncoimmunology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144528","article-title":"Mutation screening of 1,237 cancer genes across six model cell lines of basal-like breast cancer","volume":"10","author":"Olsson","year":"2015","journal-title":"PloS One"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.04.028","article-title":"DISCO interacting protein 2 determines direction of axon projection under the regulation of c-Jun N-terminal kinase in the Drosophila mushroom body","volume":"487","author":"Nitta","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2405","article-title":"Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer","volume":"44","author":"Rudin","year":"2012","journal-title":"Nat Genet"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1126\/science.1133427","article-title":"The consensus coding sequences of human breast and colorectal cancers","volume":"314","author":"Sj\u00f6blom","year":"2006","journal-title":"Science"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.21935","article-title":"Somatic mutations in the Notch, NF-KB, PIK3CA, and Hedgehog pathways in human breast cancers","volume":"51","author":"Jiao","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2006.05.015","article-title":"Multiple roles of FOXO transcription factors in mammalian cells point to multiple roles in cancer","volume":"41","author":"Arden","year":"2006","journal-title":"Exp Gerontol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2008.11.003","article-title":"Foxc2 transcription factor: a newly described regulator of angiogenesis","volume":"18","author":"Kume","year":"2008","journal-title":"Trends Cardiovasc Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2010.01.015","article-title":"The Foxc2 transcription factor regulates tumor angiogenesis","volume":"392","author":"Sano","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.19.11709","article-title":"Leupaxin is a novel LIM domain protein that forms a complex with PYK2","volume":"273","author":"Lipsky","year":"1998","journal-title":"J Biol Chem"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1210\/me.2006-0546","article-title":"Leupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cells","volume":"22","author":"Kaulfuss","year":"2008","journal-title":"Mol Endocrinol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1159\/000491536","article-title":"Leupaxin promotes bladder cancer proliferation, metastasis, and angiogenesis through the PI3K\/AKT pathway","volume":"47","author":"Hou","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B56","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jaci.2014.03.037","article-title":"Epistasis between serine protease inhibitor Kazal-type 5 (SPINK5) and thymic stromal lymphopoietin (TSLP) genes contributes to childhood asthma","volume":"134","author":"Biagini Myers","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09231.x","article-title":"A heterozygous null mutation combined with the G1258A polymorphism of SPINK5 causes impaired LEKTI function and abnormal expression of skin barrier proteins","volume":"161","author":"Di","year":"2009","journal-title":"Br J Dermatol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2078","article-title":"A novel tumor suppressor SPINK5 targets Wnt\/\u03b2-catenin signaling pathway in esophageal cancer","volume":"8","author":"Wang","year":"2019","journal-title":"Cancer Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-019-02934-x","article-title":"Amino acid transporters and exchangers from the SLC1A family: structure, mechanism and roles in physiology and cancer","volume":"45","author":"Freidman","year":"2020","journal-title":"Neurochem Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.18632\/aging.203770","article-title":"A novel 6-gene signature derived from tumor-infiltrating T cells and neutrophils predicts survival of bladder urothelial carcinoma","volume":"13","author":"Zou","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3904947","article-title":"FASN protein overexpression indicates poor biochemical recurrence-free survival in prostate cancer","volume":"2020","author":"Cao","year":"2020","journal-title":"Dis Markers"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2019.108917","article-title":"Stearoyl-CoA desaturase and tumorigenesis","volume":"316","author":"Kikuchi","year":"2020","journal-title":"Chem Biol Interact"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.45129","article-title":"The emerging role of EGFL6 in angiogenesis and tumor progression","volume":"17","author":"Kang","year":"2020","journal-title":"Int J Med Sci"},{"key":"B64","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.semcancer.2019.09.004","article-title":"Emerging roles of ECM remodeling processes in cancer","volume":"62","author":"Mohan","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2015.10.007","article-title":"In vitro cancer cell-ECM interactions inform in vivo cancer treatment","volume":"97","author":"Holle","year":"2016","journal-title":"Adv Drug Delivery Rev"},{"key":"B66","doi-asserted-by":"publisher","first-page":"360ra135","DOI":"10.1126\/scitranslmed.aaf5219","article-title":"Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases","volume":"8","author":"Rahbari","year":"2016","journal-title":"Sci Transl Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"491","DOI":"10.21873\/cgp.20152","article-title":"The FOXC2 transcription factor promotes melanoma outgrowth and regulates expression of genes associated with drug resistance and interferon responsiveness","volume":"16","author":"Hargadon","year":"2019","journal-title":"Cancer Genomics Proteomics"},{"key":"B68","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12935-021-01792-4","article-title":"Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma","volume":"21","author":"Peng","year":"2021","journal-title":"Cancer Cell Int"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30236","article-title":"CXCL6 fuels the growth and metastases of esophageal squamous cell carcinoma cells both in vitro and in vivo through upregulation of PD-L1 via activation of STAT3 pathway","volume":"236","author":"Zheng","year":"2021","journal-title":"J Cell Physiol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.5.3099","article-title":"Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells","volume":"181","author":"Matsumura","year":"2008","journal-title":"J Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02927","article-title":"Ovarian cancer-intrinsic fatty acid synthase prevents anti-tumor immunity by disrupting tumor-infiltrating dendritic cells","volume":"9","author":"Jiang","year":"2018","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32359","article-title":"Therapeutic efficacy of FASN inhibition in preclinical models of HCC","volume":"76","author":"Wang","year":"2022","journal-title":"Hepatology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12943-019-0983-5","article-title":"Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review","volume":"18","author":"Peltanova","year":"2019","journal-title":"Mol Cancer"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-018-9768-3","article-title":"Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment","volume":"37","author":"Houthuijzen","year":"2018","journal-title":"Cancer Metastasis Rev"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2230","article-title":"Kdm6a deficiency activates inflammatory pathways, promotes M2 macrophage polarization, and causes bladder cancer in cooperation with p53 dysfunction","volume":"26","author":"Kobatake","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.09.022","article-title":"The cancer immunogram as a framework for personalized immunotherapy in urothelial cancer","volume":"75","author":"van Dijk","year":"2019","journal-title":"Eur Urol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-016-2471-1","article-title":"The roles of tumor- and metastasis-promoting carcinoma-associated fibroblasts in human carcinomas","volume":"365","author":"Mezawa","year":"2016","journal-title":"Cell Tissue Res"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1986943","article-title":"CD8+ T lymphocytes are sensitive to NKG2A\/HLA-E licensing interaction: role in the survival of cancer patients","volume":"10","author":"Gimeno","year":"2021","journal-title":"Oncoimmunology"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0216","article-title":"CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful","volume":"2","author":"Kim","year":"2014","journal-title":"Cancer Immunol Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1430583\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T01:16:23Z","timestamp":1736471783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1430583\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":79,"alternative-id":["10.3389\/fimmu.2024.1430583"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1430583","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"article-number":"1430583"}}